Who can join the STRIVE Clinical Trial? Men whose prostate cancer fits this description may be able to join the STRIVE Clinical Trial: Your cancer may or may not have spread beyond the prostate Your cancer has progressed despite treatment with hormonal therapy Your cancer causes no pain or mild pain Your prostate cancer has not been previously treated with chemotherapy Your prostate [...]
by: Arnold C. Cinman, MD, FACS “an ounce of prevention is worth a pound of cure” Ben Franklin. Modern medical knowledge clearly shows that there is a gender disparity in life expectancy, morbidity, disability and health risk behavior. Men live shorter lifespans than women and die more often of 12 of the 15 most common [...]
In his over 30 years of experience as a practicing urologist, Dr. Dudley Seth Danoff has learned that most men (and women) know very little about the penis and how it functions. When men have problems in the bedroom, they assume the cause is medical and worry that the issue is permanent. The truth is [...]
International expert, urologist, and author available for comments, information, and suggestions regarding National Prostate Cancer Awareness Month MYTH: All men who have prostate cancer will have erectile dysfunction forever. This is just one of the myths that surround the often uncomfortable subject of prostate cancer. "Prostate cancer is not the kiss of death for your sex [...]
by Dudley S. Danoff, MD, FACS A study recently published in the medical journal JAMA Internal Medicine noted that prescriptions given to men 40 and older for testosterone replacement therapy (TRT) increased by 300 percent between the years 2001 and 2011. An even more astonishing fact? About one-fourth of the men involved had not received a [...]
By Matthew Bui, MD, PhDEveryone will agree that medical services are going through changes that could have a dramatic impact on how each of us receives health care. The Affordable Care Act will change the focus of health care delivery to “one-size fits all” medicine by using a statistical approach to medical decision making. Medical [...]
Tower Urology is proud to introduce a powerful new MR solution for analysis, planning and targeted biopsy of the prostate. This complete clinical MR solution for the prostate combines DynaCAD for Prostate with the UroNav fusion biopsy system - a combined solution which offers a truly new imaging option for many patients with elevated and/or [...]
by Matthew Bui, MD, PhD Da Vinci robotic surgeries have the advantage of less tissue trauma, less pain and quicker recovery. Robotic surgeries have traditionally been procedures reserved for inpatient hospitals. However, after more than 3000 robotic surgeries at Tower Urology, our patients typically only stay 1 night in the hospital. We have noticed that, [...]
by Dudley S. Danoff, MD, FACS A new study published in the Journal of the National Cancer Institute confirmed an earlier study in 2011 that found a higher risk of prostate cancer among men who consumed omega-3 fatty acids, raising new questions about the safety of fish oil supplements. Dudley S. Danoff, MD, FACS [...]
Not just industry slamming omega-3-prostate cancer links Reaction to last week’s study linking omega-3 with prostate cancer have been vociferous and near-unanimous in condemning its methods and conclusions. Here Alan Ruth, PhD, and CEO of the Irish Health Trade Association (IHTA), explains why that condemnation was justified and not just sourced from an industry concerned with [...]
